With further investigation of the PINK1-Parkin pathway, which is crucial for mitophagy, FT895 treatment was found to decrease the levels of PINK1 and Parkin proteins in MPNST cells, which may impede mitophagy. The gene discussed is PRKN; the disease is malignant peripheral nerve sheath tumor.